agence france-presse
click here to return to agence france-presse main menu
DonateNow



Malawi to double free AIDS drugs coverage by 2010

Agence France-Presse - October 5, 2007


BLANTYRE, Oct 5, 2007 (AFP) - AIDS-blighted Malawi wants to more than double the number of people receiving free anti-retroviral (ARV) drugs to 245,000 by 2010, Health Minister Marjorie Ngaunje said on Friday.

"With currently 115,000 people on ARVs, the government aims at increasing this number to 245,000 by the year 2010," Ngaunje told a conference of donors and health experts.

Though it is still a taboo subject in the conservative landlocked country, some 930,000 Malawians are living with HIV or AIDS where the prevalence rate is 14 percent, according to UNAIDS and official figures.

The conference, organised by international medical and humanitarian aid organisation Medecins Sans Frontieres (MSF), is to discuss how to deal with acute shortages of health workers.

Representatives of the United Nations Development Programme (UNDP) and the World Bank, the main sponsors of the country's economic reforms, are also attending the one-day meeting.

Saying HIV and AIDS were a major public health problem in the southern African nation, Ngaunje said: "approximately 170,000 Malawians are believed to be in urgent need of ARVs today."

She said the scale-up programme had been hit by "a persistent crisis over the past decade which is largely caused by acute shortage of professional health workers in the public health sector."

Ngaunje said the poor southern African country, with funding from the Global Fund against AIDS, malaria and tuberclosis, had recruited 5,000 health surveillance health assistants to increae access to treatment and to compensate for professional health workers.

Malawi, with a population of 12 million, has 150 doctors on the state payroll, according to a recent figure by the health ministry.

071005
AF071005


Copyright ©AFP 2007. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.